M. H. Carnegie

M.H. Carnegie & Co. is a private equity and venture capital firm established in 2010 and based in Paddington, Australia. The firm specializes in investments in startups, early-stage ventures, and expansion capital, primarily focusing on the lower to middle market in Australia and Southeast Asia. M.H. Carnegie typically invests between $0.26 million and $20.58 million per transaction and exhibits a sector-agnostic approach, targeting under-served investment opportunities across various industries. The firm has a particular emphasis on operating real estate and has launched funds such as the Carnegie Healthcare Fund, which focuses on early-stage investments in the healthcare and medical devices sectors. With total equity commitments of $132 million, M.H. Carnegie aims to capitalize on alternative investment opportunities in the post-financial crisis environment.

Matthew Beach

Partner

Mark Howard Carnegie

Founding Partner

Edward Carroll

Investment Director

Ben Ly

CFO

Trevor Moody

Managing Director

Mac Nelson

Investment Manager

Kate Thompson

Partner

9 past transactions

Ignite Tournaments

Funding Round in 2022
Ignite Tournaments is the world’s first play-to-earn esports tournament organization and streaming app for mobile games with crypto payouts.

Cardiac Dimensions

Series C in 2020
Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatment options for heart failure and associated cardiovascular conditions. The company's primary product is the Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach. This innovative device reshapes the mitral valve to reduce regurgitation, enabling less invasive procedures for patients. Founded in 2000 and headquartered in Kirkland, Washington, Cardiac Dimensions also has operations in Sydney, Australia, and Offenbach, Germany.

EBR Systems

Venture Round in 2019
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Cardiac Dimensions

Series B in 2018
Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatment options for heart failure and associated cardiovascular conditions. The company's primary product is the Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach. This innovative device reshapes the mitral valve to reduce regurgitation, enabling less invasive procedures for patients. Founded in 2000 and headquartered in Kirkland, Washington, Cardiac Dimensions also has operations in Sydney, Australia, and Offenbach, Germany.

Simplify Medical

Series B in 2018
Simplify Medical, Inc. is a medical device company that specializes in the design, development, and manufacture of cervical and lumbar artificial discs for spinal use. The company's flagship product, the Simplify Disc, is a non-metallic, motion-preserving cervical artificial disc that is compatible with magnetic resonance imaging (MRI), eliminating the need for CT imaging and reducing patient exposure to ionizing radiation. This product is specifically intended for skeletally mature patients undergoing reconstruction of a single cervical disc following discectomy for conditions such as radiculopathy. Simplify Medical markets its innovative products through distributors in various regions, including the United Kingdom and Germany. Founded in 2013 and originally known as Simplify Delaware, Inc., the company rebranded to Simplify Medical, Inc. in 2015 and is headquartered in Sunnyvale, California.

EBR Systems

Venture Round in 2017
EBR Systems, Inc. is focused on developing innovative implantable devices for cardiac rhythm management, specifically aimed at treating patients with heart failure and cardiac arrhythmias. The company's flagship product, the Wireless Cardiac Stimulation of the Left Ventricle System, utilizes proprietary wireless technology to provide endocardial pacing for cardiac resynchronization therapy. This approach enhances the heart's pumping efficiency by synchronizing the contractions of the left and right ventricles. Founded in 2003 and headquartered in Sunnyvale, California, EBR Systems is committed to advancing therapeutic options for patients suffering from cardiac rhythm diseases through its novel technologies.

Simplify Medical

Series B in 2017
Simplify Medical, Inc. is a medical device company that specializes in the design, development, and manufacture of cervical and lumbar artificial discs for spinal use. The company's flagship product, the Simplify Disc, is a non-metallic, motion-preserving cervical artificial disc that is compatible with magnetic resonance imaging (MRI), eliminating the need for CT imaging and reducing patient exposure to ionizing radiation. This product is specifically intended for skeletally mature patients undergoing reconstruction of a single cervical disc following discectomy for conditions such as radiculopathy. Simplify Medical markets its innovative products through distributors in various regions, including the United Kingdom and Germany. Founded in 2013 and originally known as Simplify Delaware, Inc., the company rebranded to Simplify Medical, Inc. in 2015 and is headquartered in Sunnyvale, California.

Cardiac Dimensions

Series A in 2015
Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatment options for heart failure and associated cardiovascular conditions. The company's primary product is the Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach. This innovative device reshapes the mitral valve to reduce regurgitation, enabling less invasive procedures for patients. Founded in 2000 and headquartered in Kirkland, Washington, Cardiac Dimensions also has operations in Sydney, Australia, and Offenbach, Germany.

Cardiac Dimensions

Series A in 2014
Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatment options for heart failure and associated cardiovascular conditions. The company's primary product is the Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach. This innovative device reshapes the mitral valve to reduce regurgitation, enabling less invasive procedures for patients. Founded in 2000 and headquartered in Kirkland, Washington, Cardiac Dimensions also has operations in Sydney, Australia, and Offenbach, Germany.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.